Ionis Pharmaceuticals, Inc.
ANGIOTENSIN II TYPE 1 RECEPTOR TARGETED OLIGONUCLEOTIDES AND USES THEREOF

Abstract:

The present disclosure provides compounds and methods for targeting cells expressing AGTR1. In some instances, the compound includes an oligonucleotide and an AGTR1 binding conjugate moiety, and optionally a conjugate linker.